Colorado Newborn Blood Spot Screening (CONBSP)


General announcements


X-ALD Go-Live Announcement

The Colorado Newborn Blood spot Screening Program (CONBSP) will begin reporting results of X-ALD screening on Feb. 9, 2023. X-linked Adrenoleukodystrophy (X-ALD) occurs when the body is unable to break down fats — specifically, very long fatty acids. The excess fat can affect the nervous system and adrenal glands. The analyte for X-ALD is C26:0 Lysophosphatidylcholine (C26:0-LPC). CONBSP’s normal range for this analyte is 0.9 umol/L blood. Abnormal results require additional second tier LC/MS testing. Report language will reflect that the testing is not complete and additional testing is being performed. Once second tier testing is complete, the report will be updated to reflect a ‘normal’ or ‘abnormal’ result. Abnormal results will be called out to both the primary care provider (PCP) and specialists at Children’s Hospital (CHCO) in Aurora. ACT sheets to provide further guidance are available at the bottom of CONBSP’s webpage. 

If you have any questions, contact Greg Bonn, manager of the Newborn Blood spot Screening Program , at 720-830-8992 or gregory.bonn@state.co.us.


Transition to E-Reports

CONBSP will no longer send out physical mailers or fax the daily reports for the newborn screen to any health facilities. The only exception includes mailing abnormal reports and sending reports to health facilities that have an established courier pick-up from the State Lab. Reports can still be requested by phone or fax by submitting a completed results request form. Prior to calling or faxing, check E-portal. If the report is unavailable, contact the birthing facility.

Sign up for an E-report account to access the portal to obtain newborn screen reports. 

If you are unable to access this document please contact cdphe_nbs_software@state.co.us.


Health care providers and laboratories

Abnormal Results | Education | Training | Quality Improvement (QI) | E-Report | Result Request | Corrections Request

Information for stakeholders

Meeting Schedule | Newsletter | Disorders | QI | Policies

Information for parents

Common Questions | Sickle Cell Information | Disorders 



  • Please Note:
    • CONBSP will accept all necessary newborn blood spot screenings for an infant up to 12 months of life. 
    • For refugee status, knowing the infant’s age will help with the interpretation of the results since they will be evaluated outside of the usual parameters.

Newborn Blood Spot Screening Phone: 303-692-3675 | Fax: 303-691-4008 | Email: cdphe_conbs@state.co.us